4.7 Review

Influence of the NR3A subunit on NMDA receptor functions

期刊

PROGRESS IN NEUROBIOLOGY
卷 91, 期 1, 页码 23-37

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.pneurobio.2010.01.004

关键词

NR3A; NMDA receptor; Synaptic plasticity; Neurodevelopmental disorders; Dendritic spine; NMDA subunit; LTP; Synapse elimination; Synapse maturation

资金

  1. NARSAD
  2. NICHD [T32-HD40127]
  3. UTE
  4. Gobierno de Navarra, Spanish Ministry of Science [SAF2006-10025, CSI2008-00005]
  5. National Science Foundation [0822969]
  6. National Eye Institute [R01EY018323]
  7. UNC Charles Lee Raper Dissertation Fellowship
  8. Society for Neuroscience/NINDS
  9. EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040127] Funding Source: NIH RePORTER
  10. NATIONAL EYE INSTITUTE [R01EY018323] Funding Source: NIH RePORTER
  11. Medical Research Council [G0001354B, G0001354] Funding Source: researchfish

向作者/读者索取更多资源

Various combinations of subunits assemble to form the NMDA-type glutamate receptor (NMDAR), generating diversity in its functions. Here we review roles of the unique NMDAR subunit, NR3A, which acts in a dominant-negative manner to suppress receptor activity. NR3A-containing NMDARs display striking regional and temporal expression specificity, and, unlike most other NMDAR subtypes, they have a low conductance, are only modestly permeable to Ca2+, and pass current at hyperpolarized potentials in the presence of magnesium. While glutamate activates triheteromeric NMDARs composed of NR1/NR2/NR3A subunits, glycine is sufficient to activate diheteromeric NR1/NR3A-containing receptors. NR3A dysfunction may contribute to neurological disorders involving NMDARs, and the subunit offers an attractive therapeutic target given its distinct pharmacological and structural properties. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据